Correction: Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation (PLoS ONE (2017) 12:2 (e0171219) DOI: 10.1371/journal.pone.0171219);Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Loomis, Zoe ^a   Eigenberger, Paul ^a   Redinius, Katherine ^a   Lisk, Christina ^a   Karoor, Vijaya ^a   Nozik Grayck, Eva ^a   Ferguson, Scott K ^a   Hassell, Kathryn ^b   Nuss, Rachelle ^b   Stenmark, Kurt ^a   Buehler, Paul ^c   Irwin, David C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; HEMOGLOBIN; HEMOPEXIN; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN INHIBITOR; TOLL LIKE RECEPTOR 9; TLR9 PROTEIN, MOUSE; TLR9 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY ENDOTHELIUM; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL PROLIFERATION; CELL SPECIFICITY; COCULTURE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; IN VIVO STUDY; LIPID PEROXIDATION; LUNG ARTERY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION; VASCULAR ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE CELL; ANEMIA, HEMOLYTIC; ANIMAL; C57BL MOUSE; HYPERTENSION, PULMONARY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; PULMONARY ARTERY; VASCULAR SMOOTH MUSCLE;

ANEMIA, HEMOLYTIC; ANIMALS; CELL PROLIFERATION; FEMALE; HEMOGLOBINS; HYPERTENSION, PULMONARY; INTERLEUKIN-6; LIPID PEROXIDATION; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; TOLL-LIKE RECEPTOR 9;

EID: 85011324285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0173652     Document Type: Erratum

References (45)

1. Gladwin MT. Revisiting the hyperhemolysis paradigm. Blood. 2015; 126(6):695-6. doi:10.1182/blood-2015-06-649491 PMID: 26251222.
2. Shaver CM, Upchurch CP, Janz DR, Grove BS, Putz ND, Wickersham NE, et al. Cell-free hemoglobin: A novel mediator of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2016; 310(6): L532-L41. doi:10.1152/ajplung.00155.2015 PMID: 26773065.
3. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-Associated acute kidney injury. J Am Coll Cardiol. 2010; 55(19):2024- 33. doi:10.1016/j.jacc.2009.12.046 PMID: 20447525.
4. Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front Physiol. 2014; 5:415. doi:10.3389/fphys.2014.00415 PMID: 25389409.
5. Chintagari NR, Jana S, Alayash AI. Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells. Am J Respir Cell Mol Biol. 2016.
6. Gladwin M, Vichinsky E. Pulmonary complications of sickle cell disease. New England journal of medicine. 2008; 359(21):2254-65. doi:10.1056/NEJMra0804411 PMID: 19020327.
7. Gladwin MT, Kato GJ. Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia. Hematology. 2005; 2005(1):51-7.
8. Kato G, Taylor J. Pleiotropic effects of intravascular haemolysis on vascular homeostasis. British Journal of Hematology. 2009:1-12.
9. Kato GJ. Novel Small Molecule Therapeutics for Sickle Cell Disease: Nitric Oxide, Carbon Monoxide, Nitrite, and Apolipoprotein A-I. Hematology. 2008; 2008(1):186-92.
10. Schaer CA, Deuel JW, Schildknecht D, Mahmoudi L, Garcia-Rubio I, Owczarek C, et al. Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis. Am J Respir Crit Care Med. 2016; 193 (10):1111-22. doi:10.1164/rccm.201510-2058OC PMID: 26694989.
11. Schaer DJ, Buehler PW. Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies. Cold Spring Harb Perspect Med. 2013; 3(6).
12. Smith A, McCulloh RJ. Hemopexin and haptoglobin: Allies against heme toxicity from hemoglobin not contenders. Front Physiol. 2015; 6:187. doi:10.3389/fphys.2015.00187 PMID: 26175690.
13. Lisk C, Kominsky D, Ehrentraut S, Bonaventura J, Nuss R, Hassell K, et al. Hemoglobin-induced endothelial cell permeability is controlled, in part, via a MYD88 dependent signaling mechanism. Am J Resp and Mol Bio. 2013 in press.
14. Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares M. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. The journal of bilogical chemistry. 2009; 284 (43).
15. Zhu J, Mohan C. Toll-like receptor signaling pathways-Therapeutic opportunities. Mediators of inflammation. 2010; 2010:7.
16. Pisetsky DS. The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunol. 2012; 144(1):32-40. doi:10.1016/j.clim.2012.04.006 PMID: 22659033.
17. Ding Z, Liu S, Wang X, Khaidakov M, Dai Y, Mehta JL. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep. 2013; 3:1077. doi:10.1038/srep01077 PMID: 23326634.
18. Madathilparambil SV, Thomas B, Dolgachev VA, Sherman MA, Goldberg R, Johnson M, et al. Toll Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion. Shock. 2016.
19. Tsuji N, Tsuji T, Ohashi N, Kato A, Fujigaki Y, Yasuda H. Role of Mitochondrial DNA in Septic AKI via Toll-Like Receptor 9. J Am Soc Nephrol. 2015.
20. Schumacker PT, Gillespie MN, Nakahira K, Choi AM, Crouser ED, Piantadosi CA, et al. Mitochondria in lung biology and pathology: More than just a powerhouse. Am J Physiol Lung Cell Mol Physiol. 2014; 306(11):L962-74. doi:10.1152/ajplung.00073.2014 PMID: 24748601.
21. Irwin DC, Hyen Baek J, Hassell K, Nuss R, Eigenberger P, Lisk C, et al. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med. 2015; 82:50-62. doi:10.1016/j.freeradbiomed.2015.01.012 PMID: 25656991.
22. Kelly JJ, Moore TM, Babal P, Diwan AH, Stevens T, Thompson WJ. Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability. Am J Physiol. 1998; 274(5 Pt1):L810-L9. PMID: 9612297.
23. Gu X, Wu G, Yao Y, Zeng J, Shi D, Lv T, et al. Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway. Free Radic Biol Med. 2015; 83:149-58. doi:10.1016/j.freeradbiomed.2015.02.034 PMID: 25772007.
24. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol. 2008; 9(12):1407-14. doi:10.1038/ni.1669 PMID: 18931679.
25. Mitchell S, Vargas J, Hoffmann A. Signaling via the NFkappaB system. Wiley Interdiscip Rev Syst Biol Med. 2016; 8(3):227-41. doi:10.1002/wsbm.1331 PMID: 26990581.
26. Damm J, Wiegand F, Harden LM, Wenisch S, Gerstberger R, Rummel C, et al. Intraperitoneal and subcutaneous injections of the TLR9 agonist ODN 1668 in rats: brain inflammatory responses are related to peripheral IL-6 rather than interferons. J Neuroimmunol. 2014; 277(1-2):105-17. doi:10.1016/j.jneuroim.2014.10.007 PMID: 25465287.
27. Poulain L, Richard V, Levy P, Dematteis M, Arnaud C. Toll-like receptor-4 mediated inflammation is involved in the cardiometabolic alterations induced by intermittent hypoxia. Mediators Inflamm. 2015; 2015:620258. doi:10.1155/2015/620258 PMID: 25873766.
28. Vaidya B, Gupta V. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery. J Control Release. 2015; 211:118-33. doi:10.1016/j.jconrel.2015.05.287 PMID: 26036906.
29. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. Jama. 2005; 293(13):1653-62. doi:10.1001/jama.293.13.1653 PMID: 15811985.
30. Deuel JW, Schaer CA, Boretti FS, Opitz L, Garcia-Rubio I, Baek JH, et al. Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response. Cell Death Dis. 2016; 7:e2064. doi:10.1038/cddis.2015.392 PMID: 26794659.
31. Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood. 2009; 113(11):2578-86. doi:10.1182/blood-2008-08-174466 PMID: 19131549.
32. Vallelian F, Garcia-Rubio I, Puglia M, Kahraman A, Deuel JW, Engelsberger WR, et al. Spin trapping combined with quantitative mass spectrometry defines free radical redistribution within the oxidized hemoglobin:haptoglobin complex. Free Radic Biol Med. 2015; 85:259-68. doi:10.1016/j.freeradbiomed.2015.04.023 PMID: 25933590.
33. Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, et al. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. The Journal of Clinical Investigation. 2009; 119(8):2271-80. doi:10.1172/JCI39115 PMID: 19620788.
34. Kuck JL, Obiako BO, Gorodnya OM, Pastukh VM, Kua J, Simmons JD, et al. Mitochondrial DNA damage-Associated molecular patterns mediate a feed-forward cycle of bacteria-induced vascular injury in perfused rat lungs. Am J Physiol Lung Cell Mol Physiol. 2015; 308(10):L1078-L85. doi:10.1152/ajplung.00015.2015 PMID: 25795724.
35. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: An irondependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. doi:10.1016/j.cell.2012.03.042 PMID: 22632970.
36. Wallach D, Kang TB, Dillon CP, Green DR. Programmed necrosis in inflammation: Toward identification of the effector molecules. Science. 2016; 352(6281):aaf2154. doi:10.1126/science.aaf2154 PMID: 27034377.
37. Chouteau JM, Obiako B, Gorodnya OM, Pastukh VM, Ruchko MV, Wright AJ, et al. Mitochondrial DNA integrity may be a determinant of endothelial barrier properties in oxidant-challenged rat lungs. Am J Physiol Lung Cell Mol Physiol. 2011; 301(6):L892-L8. doi:10.1152/ajplung.00210.2011 PMID: 21890512.
38. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease. New England Journal of Medicine. 2004; 350(9):886-95. doi:10.1056/NEJMoa035477 PMID: 14985486.
39. Tuder RM, Archer SL, Dorfmuller P, Erzurum SC, Guignabert C, Michelakis E, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D4- D12. doi:10.1016/j.jacc.2013.10.025 PMID: 24355640.
40. Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S. Pathology of Pulmonary Hypertension. Clinics in Chest Medicine. 2007; 28(1):23-42. doi:10.1016/j.ccm.2006.11.010PMID: 17338926.
41. Hiram R, Rizcallah E, Marouan S, Sirois C, Sirois M, Morin C, et al. Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-Alpha-And IL-6-pretreated human pulmonary arteries. Am J Physiol Lung Cell Mol Physiol. 2015; 309(8):L776-L88. doi:10.1152/ajplung.00177.2015PMID: 26320154.
42. Stenmark KR, Tuder RM, El Kasmi KC. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension. J Appl Physiol (1985). 2015; 119(10):1164- 72.
43. Buehler PW, Baek JH, Lisk C, Connor I, Sullivan S, Kominsky D, et al. Free Hemolgobin Induction of Pulmonary Vascular Disease: Evidence for and inflammatory Mechanism. Am J Physiol Lung Cell Mol Physiol. 2012; 303(4):312-26.
44. Opitz B, Eitel J, Meixenberger K, Suttorp N. Role of Toll-like receptors, NOD-like receptors and RIG-Ilike receptors in endothelial cells and systemic infections. Thromb Haemost. 2009; 2009(102):1103-9.
45. Belcher JD, Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2013.